Cargando…
Disulfiram Inhibits Epithelial–Mesenchymal Transition Through TGFβ–ERK–Snail Pathway Independently of Smad4 to Decrease Oral Squamous Cell Carcinoma Metastasis [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630542/ https://www.ncbi.nlm.nih.gov/pubmed/34858055 http://dx.doi.org/10.2147/CMAR.S348759 |
Ejemplares similares
-
Disulfiram inhibits epithelial–mesenchymal transition through TGFβ–ERK–Snail pathway independently of Smad4 to decrease oral squamous cell carcinoma metastasis [Corrigendum]
por: Bu, Wenhuan, et al.
Publicado: (2019) -
Disulfiram inhibits epithelial–mesenchymal transition through TGFβ–ERK–Snail pathway independently of Smad4 to decrease oral squamous cell carcinoma metastasis
por: Bu, Wenhuan, et al.
Publicado: (2019) -
[Corrigendum] MicroRNA-133b targets TGFβ receptor I to inhibit TGF-β-induced epithelial-to-mesenchymal transition and metastasis by suppressing the TGF-β/SMAD pathway in breast cancer
por: Wang, Shengjie, et al.
Publicado: (2023) -
[Corrigendum] Thymoquinone inhibits epithelial‑mesenchymal transition in prostate cancer cells by negatively regulating the TGF‑β/Smad2/3 signaling pathway
por: Kou, Bo, et al.
Publicado: (2023) -
Corrigendum to “The Chinese Medicine, Jiedu Recipe, Inhibits the Epithelial Mesenchymal Transition of Hepatocellular Carcinoma via the Regulation of Smad2/3 Dependent and Independent Pathways”
por: Liang, Shufang, et al.
Publicado: (2022)